Krishna Institute of Medical Sciences (KIMS) Fundamentals 2026 — P/E 130.3x, Revenue Analysis | SniperIQ
Krishna Institute of Medical Sciences (KIMS) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹31,490 Crore, trading at ₹784.15 on the BSE. This SniperIQ fundamentals page covers Krishna Institute of Medical Sciences's valuation (P/E 130.3x, P/B 14.0x), profitability (net margin 6.2%), revenue (₹3,905 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Krishna Institute of Medical Sciences's market cap?
Krishna Institute of Medical Sciences (KIMS) has a market capitalization of approximately ₹31,490 Crore, trading at ₹784.15 on the BSE. Market cap moves with the live share price.
What is Krishna Institute of Medical Sciences's P/E ratio?
Krishna Institute of Medical Sciences's trailing twelve-month P/E ratio is 130.3x, with a price-to-book (P/B) of 14.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Krishna Institute of Medical Sciences?
Krishna Institute of Medical Sciences runs a net profit margin of 6.2%, a gross margin of 68.6%, and an operating margin of 13.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Krishna Institute of Medical Sciences generate?
Krishna Institute of Medical Sciences reported revenue of ₹3,905 Crore for fiscal year 2026, with net income of ₹241 Crore and earnings per share (EPS) of 6.03. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Krishna Institute of Medical Sciences pay a dividend?
Krishna Institute of Medical Sciences does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Krishna Institute of Medical Sciences financially healthy?
Krishna Institute of Medical Sciences carries a debt-to-equity ratio of 1.89x and a current ratio of 0.76x, with a market beta of 0.18. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Krishna Institute of Medical Sciences a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Krishna Institute of Medical Sciences (KIMS) the key facts are: market cap ₹31,490 Crore, P/E 130.3x, revenue ₹3,905 Crore, 52-week range 575.55-858.15. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Krishna Institute of Medical Sciences's full fundamentals live
Get Krishna Institute of Medical Sciences's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.